Mogamulizumab, an anti-CCR4 monoclonal antibody, is a potent therapeutic option for adult T-cell leukemia-lymphoma

ABSTRACT:

SUBMITTER: Utsunomiya A 

PROVIDER: S-EPMC4043637 | biostudies-literature | 2014 Jan

REPOSITORIES: biostudies-literature